Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Multiple Myeloma
100%
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
100%
Comorbidity Index
100%
Hematopoietic Cell Transplant
100%
Index Score
66%
Non-relapse Mortality
46%
Confidence Interval
20%
Karnofsky Performance Status
20%
Relative Risk
13%
Overall Survival
13%
Comorbidity
6%
Multivariate Analysis
6%
Cox Regression Model
6%
Disease Progression
6%
Morbidity Mortality
6%
Pretransplant
6%
Marrow Transplantation
6%
Dose Reduction
6%
Potential Prognostic Factors
6%
Allogeneic Transplantation
6%
Induction Regimen
6%
Resistant Disease
6%
Multivariate Cox Regression
6%
High-dose Melphalan
6%
Medicine and Dentistry
Multiple Myeloma
100%
Transplantation
100%
Cell Transplantation
100%
Comorbidity
100%
Hematopoietic Cell
100%
Autologous Hematopoietic Stem Cell Transplantation
37%
Karnofsky Performance Status
18%
Overall Survival
12%
Melphalan
12%
High Risk Population
6%
Multivariate Analysis
6%
Drug Megadose
6%
Cohort Analysis
6%
Proportional Hazards Model
6%
Allograft
6%
Disease Exacerbation
6%
Prognostic Factor
6%
Immunoglobulin A
6%
Drug Dose Reduction
6%
Diseases
6%
Immunology and Microbiology
Hematopoietic Cell
100%
Cell Transplantation
100%
Multiple Myeloma
100%
Comorbidity
100%
Autologous Hematopoietic Stem Cell Transplantation
37%
Overall Survival
12%
High Risk Population
6%
Immunoglobulin A
6%
Drug Megadose
6%
Drug Dose Reduction
6%
Allograft
6%
Biochemistry, Genetics and Molecular Biology
Cell Transplantation
100%
Comorbidity
100%
Hematopoietic Cell
100%
Melphalan
12%
Overall Survival
12%
High Risk Population
6%
Multivariate Analysis
6%
Immunoglobulin A
6%
Drug Megadose
6%
Cohort Study
6%
Drug Dose Reduction
6%
Mathematics
Confidence Interval
100%
Relative Risk
66%
Regression Model
33%
Proportional Hazards Model
33%
Disease Progression
33%
Multivariate Analysis
33%